openPR Logo
Press release

Erosive Esophagitis Market Report 2023-2033 | Industry Size, Growth and Latest Insights

09-26-2023 04:14 PM CET | Health & Medicine

Press release from: IMACR Group

Erosive Esophagitis Market Report 2023-2033 | Industry Size,

Erosive Esophagitis Market Report Overview:  

Report Attribute Details
Base Year 2022
Forecast Years 2023-2033
Historical Years 2017-2022
Market Growth (2023-2033) 20%

The report offers a comprehensive analysis of the erosive esophagitis market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market's performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the erosive esophagitis market.

Request for a Sample Copy of this Report:
https://www.imarcgroup.com/erosive-esophagitis-market/requestsample

The 7 major erosive esophagitis markets are expected to exhibit a CAGR of 20% during 2023-2033.Erosive esophagitis represents a medical issue marked by inflammation and harm to the esophagus lining. The market for erosive esophagitis is seeing a notable surge, largely fueled by a set of major factors contributing to its growth. The rising cases of gastroesophageal reflux disease (GERD), a principal cause of erosive esophagitis, have accelerated market expansion. Various associated elements, such as lifestyle changes, eating habits, and an aging demographic, are boosting the occurrence of GERD, which in turn affects the erosive esophagitis market directly. Progress in diagnostic methods, including endoscopy and pH testing, is enhancing the early detection and precise identification of the condition. This has facilitated prompt intervention and specialized treatment, increasing market demand. Greater awareness among both healthcare providers and patients about the issues related to untreated erosive esophagitis has led to timely medical management, which is also contributing to the market expansion.

The advent of new and efficient drugs has broadened the scope of the erosive esophagitis market. Medicines like proton pump inhibitors (PPIs), antacids, and histamine receptor blockers are increasingly being utilized. Additionally, the formulation of advanced pharmaceutical products has improved patient adherence. Pharma firms and medical research bodies are investing robustly in deciphering the root causes of erosive esophagitis and creating novel treatments. Furthermore, due to a rising elderly population, the incidence of erosive esophagitis is likely to increase. Age-related alterations in the digestive system make older individuals more susceptible, driving market expansion. The enhancement and enlargement of healthcare systems, especially in emerging regions, have augmented patient access to diagnostic and therapeutic services. This, along with the multiple factors mentioned above, is poised to propel the erosive esophagitis market in the foreseeable future.

Countries Covered:

United States
Germany
France
United Kingdom
Italy
Spain
Japan

Analysis Covered Across Each Country:

Historical, current, and future epidemiology scenario
Historical, current, and future performance of the erosive esophagitis market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the erosive esophagitis market
Reimbursement scenario in the market
In-market and pipeline drugs

This report also provides a detailed analysis of the current erosive esophagitis marketed drugs and late-stage pipeline drugs.

In-Market Drugs:

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Late-Stage Pipeline Drugs:

Drug overview
Mechanism of action
Regulatory status
Clinical trial results
Drug uptake and market performance

Competitive Landscape With Key Players:

The competitive landscape of the erosive esophagitis market has been studied in the report with the detailed profiles of the key players operating in the market.

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=9338&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Other Related Reports: 

Chronic Lymphocytic Leukemia Market

Niemann Pick Disease Type C Market

Lamellar Ichthyosis Market  

Contact Us:

IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Erosive Esophagitis Market Report 2023-2033 | Industry Size, Growth and Latest Insights here

News-ID: 3223600 • Views:

More Releases from IMACR Group

Canned Food Manufacturing Plant Cost 2025: Setup Details, Capital Investments, and Business Plan
Canned Food Manufacturing Plant Cost 2025: Setup Details, Capital Investments, a …
Canned food refers to food products that are preserved and packaged in airtight containers to extend shelf life while retaining taste, nutrients, and safety. The process involves cleaning, processing, sealing, and sterilizing food items such as fruits, vegetables, seafood, meats, and ready-to-eat meals. Canning protects against spoilage caused by bacteria, yeast, and molds, ensuring long-term storage and easy transportation. This convenience, combined with increasing demand for quick and nutritious meal
Q2 2025 Electrical Steel Prices Trend Upward Driven by Automotive & Renewable Energy Sectors
Q2 2025 Electrical Steel Prices Trend Upward Driven by Automotive & Renewable En …
North America Electrical Steel Prices Movement Q2 2025: Electrical Steel Prices in USA: During Q2 2025, electrical steel prices in the USA reached 5915 USD/MT in June. The price trend showed upward pressure due to rising raw material costs, particularly silicon and iron ore. The price chart highlighted robust demand from automotive and renewable energy sectors, while mill maintenance and elevated freight charges influenced the price index. Trade policy uncertainties further affected
GCC E-Commerce Market Size To Worth USD 2,020.6 Billion by 2033 | CAGR of 15.3%
GCC E-Commerce Market Size To Worth USD 2,020.6 Billion by 2033 | CAGR of 15.3%
GCC E-Commerce Market Overview Market Size in 2024: USD 507.2 Billion Market Size in 2033: USD 2,020.6 Billion Market Growth Rate 2025-2033: 15.3% According to IMARC Group's latest research publication, "GCC E-Commerce Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC e-commerce market size was valued at USD 507.2 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 2,020.6 Billion by 2033, exhibiting a CAGR of 15.3%
Steel Wire Rod Price Index 2025: Current Prices, Historical Trends, and Future Outlook
Steel Wire Rod Price Index 2025: Current Prices, Historical Trends, and Future O …
North America Steel Wire Rod Prices Movement Q2 2025: Steel Wire Rod Prices in United States: In Q2 2025, steel wire rod prices in the USA reached 1241 USD/MT. Rising construction activities and automotive demand supported firm market sentiment. Elevated energy expenses and raw material costs further influenced pricing. Trade regulations and supply chain adjustments also played a role, while seasonal fluctuations and infrastructure projects maintained steady demand, keeping market conditions stable

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase